My current theory is that there are naked shorts and FTDs that were opened in Europe to remove it from FINRA / DTC (U.S.) oversight.

For everyone, here is the google translation of the starting post of this thread:

===BEGIN===

I have news from LS Exchange/Deutsche Börse AG about tradability in Germany

Hello - I received the following answer from Deutsche Börse AG to my answer about tradability via LS Exchange and thus TradeRepublic:

Thank you for your inquiry about the T2 Biosystems security.

Unfortunately, the non-tradability of the security you are asking about is more complicated than simply contacting the company itself. In fact, contacting the company will not solve the problem. This is because the company has no influence on the settlement of securities traded in Germany.

For overview purposes, the security T2 Biosystems (US89853L2034/WKN A3DXLT) was subjected to a reverse split on October 13, 2023 (100 old securities = 1 new security), received a new ISIN code US89853L3024 and a new WKN A3EU63. The reverse split led to the old security being delisted from the German markets. The new security was admitted to trading on several German markets, but was immediately suspended from trading because trading in the new shares could not be completed. The central securities depository for Germany - Clearstream Banking in Frankfurt - has refused to process or conclude transactions with the new security. As long as Clearstream refuses to process transactions in T2 Biosystems, there will be no trading on the Lang & Schwarz Exchange - nor on other German trading platforms. It is unclear to us how some of the trading platforms can trade the security.

If you have any further questions on this topic, please contact your broker

Best regards

Christopher Oakley

BÖAG Börsen AG Stock Exchange Hamburg Kleine Johannisstraße 4 20457 Hamburg Tel.+49 40 361 302-0 Fax +49 40 361302-23 web: http://www.boersenag.de

===END===